ResMed heart attack trial stopped after putting patients at risk, page-24

Currency effect hurt the SP last year so that is why the results were affected this reporting season. That currency play has reversed since adn will benefit Australia in the upcoming reports.

On Sky business, the analyst Mathan Somasandran said the company has good management, a good business model and a good product line. He said it was like CSL, so just stand through the cycle and things will recover. He also said RMD is making huge gains in Asia and they are growing at an accelerating pace.

The company put out a statement indicating they are further analysing the data to see if there isn't something skewed with the data analysis. This result potentially affects 2% of the customer base on current year figures. This is so overdone its not funny. Big boys rubbing hands with glee, they dream of opps like these, Resmed is a dream company in the health sector. I am very comfortable holding and topping today.